More NewsRead More
Intellipharmaceutics Announces Third Quarter 2014 Results
October 15, 2014
Intellipharmaceutics Announces Resignation of Chief Financial Officer
September 30, 2014
Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology
August 28, 2014
Top Performing Industries For October 23, 2014
October 23, 2014
Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement
May 20, 2014
Intellipharmaceutics Reports Positive Results From A Series of Phase I Clinical Trials Of Regabatin XR
October 22, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here